Plenum Publishing Corp. – Trademark Portfolio

Entity Type: 03

Plenum Publishing Corp. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 7 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include CATALYSIS LETTERS, PHARMACEUTICAL RESEARCH, DIGESTIVE DISEASES AND SCIENCES, JOURNAL OF LOW TEMPERATURE PHYSICS, and JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS. The owner is based in New York, NY.

223 Spring Street

New York, NY 100131578

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Plenum Publishing Corp.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (7 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does Plenum Publishing Corp. have?

Plenum Publishing Corp. has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 cancelled.

What trademark classes does Plenum Publishing Corp. file in?

Plenum Publishing Corp. files trademarks across 1 Nice Classification class. The most active classes are Class 16 (Paper Goods). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are Plenum Publishing Corp.'s most well-known trademarks?

Plenum Publishing Corp.'s registered trademark portfolio includes well-known marks such as CATALYSIS LETTERS, PHARMACEUTICAL RESEARCH, DIGESTIVE DISEASES AND SCIENCES, JOURNAL OF LOW TEMPERATURE PHYSICS, and JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS. These are among 6 currently registered trademarks in the portfolio.

What is Plenum Publishing Corp.'s trademark registration success rate?

Plenum Publishing Corp. has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.